Inventiva Pharma Employee Directory
Biotechnology ResearchBourgogne-franche-comté, France51-200 Employees
Inventiva Pharma is a France-based biotechnology company focused on research and development for metabolic dysfunction-associated steatohepatitis (MASH). The firm treats MASH as both a liver disease and a broader cardiometabolic condition, aiming to restore metabolic balance by addressing inflammation and fibrosis at the disease's source. Based in Daix near Dijon in the Bourgogne-Franche-Comté region, it operates as a mid-sized biotechnology company pursuing differentiated therapies for this progressive condition. Its lead candidate, lanifibranor, is in global Phase 3 development and has received FDA Breakthrough Therapy Designation. The program targets patients affected by MASH, seeking to relieve a significant unmet medical need by intervening at the inflammatory and fibrotic processes that drive disease progression.